retatrutide triple agonist glp-1 gip glucagon phase 3 2025 The Science Behind Retatrutide: A New Hope for Obesity and Diabetes – Prime Lab Peptides Retatrutide vs Tirzepatide Compared |

In clinical research, participants taking tirzepatide had average systolic blood pressure reductions of about 7.4 to 10.6 mm Hg after 36 weeks

Libido: moving in both directions 35% reported no change 29% reported higher libido 19% reported lower libido Body confidence and sex life 70% of women reported improvements in body confidence and sex life Mood and lifestyle changes 45% said their mood became more stable 53% lost interest in foods they previously enjoyed 49% reported reduced desire to drink alcohol What this tells us GLP-1 may influence behavior, emotional state, habits

Understanding these variables helps contextualise any changes observed during treatment and prevents unnecessary anxiety

Research on GLP-1 therapy discontinuation suggests that certain metabolic improvements show partial persistence even after weight regain

Ozempic (semaglutide) is a GLP-1 receptor agonist

prescribed off-label for weight loss Estimated retail price: $950$1,200/month Zepbound (tirzepatide) FDA approved for weight loss Estimated retail price: $1,080$1,200/month Mounjaro (tirzepatide) FDA approved for type 2 diabetes